Skip to main content

Table 1 Baseline characteristics of lung adenocarcinoma patient in the TCGA dataset

From: Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation

 

TCGA (N = 497)

Gender

(%)

 Male

228 (46.2%)

 Female

269 (53.8%)

Age at diagnosis

(%)

  < =70 years old

327 (67.1%)

  > 70 years old

160 (32.9%)

T stage

(%)

 T1

166 (33.6%)

 T2&T3&T4

328 (66.4%)

N stage

 N0

321 (66.0%)

 N1&N2&N3

165 (34.0%)

M stage

 M0

331 (93.2%)

 M1

24 (6.8%)

Pathological stage

 stage1

267 (54.5%)

 stage2&3&4

223 (45.5%)

SEC61G expression

 Low

273 (54.9%)

 High

224 (45.1%)

Vital status

 Dead

180 (36.2%)

 Alive

317 (63.8%)